✦ LIBER ✦

Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)

✍ Scribed by V. Usonis; V. Bakasénas; R. Valentelis; G. Katiliene; D. Vidzeniene; C. Herzog

Book ID: 117431805
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 68 KB
Volume: 21
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(03)00509-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of Booster Vaccination wi

Immunogenicity of Booster Vaccination with a Virosomal Hepatitis A Vaccine after Primary Immunization with an Aluminum-adsorbed Hepatitis A Vaccine

✍ Bernard R. Beck; Christoph F. R. Hatz; Louis Loutan; Robert Steffen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Immunogenicity and safety of a virosomal

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in healthy toddlers and children in Chile

✍ S Riedemann; G Reinhardt; H Ibarra; GG Frösner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs

Estimated persistence of anti-HAV antibo

Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule)

✍ G. Wiedermann; M. Kundi; F. Ambrosch 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Antibody persistence and the effect of a

Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine

✍ Vladimir Gilca; Gaston De Serres; Nicole Boulianne; Donald Murphy; Philippe De W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Persistence of hepatitis A vaccine induc

Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up

✍ Umid M. Sharapov; Lisa R. Bulkow; Susan E. Negus; Philip R. Spradling; Chriss Ho 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB